Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors

Figure 3

Effect of VEGF-C overexpression on PC-3 prostate tumor growth. The occurrence of subcutaneous tumors of both PC-3/VEGF-C (n = 8) and PC-3/mock (n = 12) was 100%. (A) Subcutaneous PC-3/VEGF-C tumors grew larger (1132 ± 34 mm3, gray bars) than PC-3/mock tumors (47 ± 7 mm3, black bars) at 4 weeks and the differences in tumor volumes between the groups were significant at all time points between 2 and 4 weeks (p < 0.001). (B) The occurrence of orthotopical tumors was 88% (n = 29 out of 33 mice) in the PC-3/VEGF-C group and 86% (n = 24 out of 28 mice) in the control group. The mean volume of the PC-3/VEGF-C tumors was 400 ± 17 mm3 (n = 29) and in PC-3/mock tumors it was 48 ± 4 mm3 (n = 24), p < 0.001.

Back to article page